FBXO28 targets SNAI1 for ubiquitin-proteasomal degradation in non-small cell lung cancer
Journal of Biological Chemistry · 2026
DOI: 10.1016/j.jbc.2026.113405 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026. Verfasst von Jingyu Lin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Snail Family Transcription Factors, Lung Neoplasms, Proteasome Endopeptidase Complex. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Chinese Academy of Medical Sciences Initiative for Innovative Medicine.
Abstract (Originalsprache)
SNAI1 is a central regulator of the epithelial-mesenchymal transition, which is highly unstable and degraded through the ubiquitin-proteasome system. Although a panel of E3 ubiquitin ligases responsible for SNAI1 degradation have been discovered, whether there exists other E3 ubiquitin ligase remains unclarified. In this study, we demonstrate that FBXO28 expression is downregulated in non-small cell lung cancer (NSCLC) tissues compared to adjacent non-cancerous tissues, correlating with beneficial patient prognosis. Specifically, FBXO28 physically interacts with SNAI1, promoting its polyubiquitination and degradation in a mechanism dependent on phosphorylation by glycogen synthase kinase-3β (GSK3β). Functional assays indicate that FBXO28 controls the half-life of SNAI1 protein, which are abrogated by proteasome inhibitor MG132 in NSCLC cells. Importantly, FBXO28 suppresses the migratory and invasive abilities of NSCLC cells, an effect that can be mitigated by GSK3β inhibition. We also present data to show that SNAI1, along with SNAI2, mediates the regulatory function of FBXO28 toward migration and invasion of NSCLC cells in mice and zebrafish xenograft models. Collectively, our findings elucidate a significant role for FBXO28 in regulating SNAI1 stability via the ubiquitin-proteasome system, thereby providing insights into therapeutic strategies aimed at constraining metastasis in NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- Department of Thoracic Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Biochemistry, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Electronic address: shenjiajia@imb.pumc.edu.cn.
- Department of Biochemistry, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Electronic address: wangzhen@imb.pumc.edu.cn.
Förderung
- National Natural Science Foundation of China
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine
Zitieren
APA
Lin, J., Qiao, X., Liu, H., Chen, Y., Li, Z., Tong, X., Shen, M., Zhang, R., Han, Y., Shen, J., & Wang, Z. (2026). FBXO28 targets SNAI1 for ubiquitin-proteasomal degradation in non-small cell lung cancer. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2026.113405
Vancouver
Lin J, Qiao X, Liu H, Chen Y, Li Z, Tong X, et al. FBXO28 targets SNAI1 for ubiquitin-proteasomal degradation in non-small cell lung cancer. Journal of Biological Chemistry. 2026. doi:10.1016/j.jbc.2026.113405
BibTeX
@article{Lin2026,
author = {Lin, Jingyu and Qiao, Xinran and Liu, Hua and Chen, Yang and Li, Zhen and Tong, Xinyi and Shen, Mi and Zhang, Rui and Han, Ying and Shen, Jiajia and Wang, Zhen},
title = {FBXO28 targets SNAI1 for ubiquitin-proteasomal degradation in non-small cell lung cancer},
journal = {Journal of Biological Chemistry},
year = {2026},
doi = {10.1016/j.jbc.2026.113405}
}
EUVIMED